New Test Predicts Recurrence Rate in Early-Stage Invasive Breast Cancer Patients
The AidaBreast novel biosignature also predicts radiation therapy benefit for early-stage invasive breast cancer patients.
Read MorePosted by Andy Lundin | Mar 14, 2024 | Breast |
The AidaBreast novel biosignature also predicts radiation therapy benefit for early-stage invasive breast cancer patients.
Read MorePosted by Andy Lundin | Mar 13, 2024 | Diagnostic Technologies |
Physicians Lab, a provider of at-home lab testing, launched a new at-home lab test that measures the analytes myostatin and follistatin.
Read MorePosted by Andy Lundin | Mar 12, 2024 | Flow Cytometry Instruments |
The DxFLEX Flow Cytometer is designed to make multicolor flow cytometry less complex by harnessing APD detector technology.
Read MorePosted by Andy Lundin | Mar 11, 2024 | Cancer, Molecular Diagnostics |
The Florida Health Department will use DiaCarta’s RadTox test for early detection of cancer treatment response and resistance.
Read MorePosted by Andy Lundin | Mar 8, 2024 | Immunoassay Reagents & test Kits, Womens Health |
The test is for use with the Triage MeterPro for the quantitative determination of placental growth factor in maternal plasma specimens.
Read More